Polymerizable compound and optically anisotropic body
US-2018319755-A1 · Nov 8, 2018 · US
US2016200703A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016200703-A1 |
| Application number | US-201414912479-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 20, 2014 |
| Priority date | Aug 20, 2013 |
| Publication date | Jul 14, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure is generally directed to compositions and methods for treating diseases that are ameliorated by the inhibition of CYP26 mediated retinoic acid metabolism. The compositions comprise compounds of formula (I). A repreid50000060307390 IB/345 nullsents aryl optionally substituted with one, two, three, or four groups that are each independently halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, and C 1 -C 6 haloalkoxy; X is a bond, —CH 2 —, —CHR 5 —, —C═CHR 4 —, —NR 4 —, —N═O—R 4 —, —O—, —S—, —SO—, —SO 2 —, —C(O)—, or —C(NR 4 )—, or X is of formula (a), (b) or (c), wherein each n is independently 1, 2, or 3; each R 4 is independently hydrogen or C 1-6 alkyl; R 5 is independently hydrogen, C 1-6 alkyl, or —OR 6 , where R 6 is selected from the group consisting of hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyL C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroarylC 1-6 alkyl; Y is C 1-6 alkylene, C 2-6 alkenylene, or C 2-6 alkylylene moiety.
Opening claim text (preview).
We claim: 1 . A compound of the formula (I): or a pharmaceutically acceptable salt thereof, wherein A represents aryl optionally substituted with one, two, three, or four groups that are each independently halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, and C 1 -C 6 haloalkoxy; X is a bond, —CH 2 —, —CHR 5 —, —C═CHR 4 —, —NR 4 —, —N═O—R 4 , —O—, —S—, —SO—, —SO 2 —, —C(O)—, or —C(NR 4 )—, or X is of formula wherein each n is independently 1, 2, or 3; each R 4 is independently hydrogen or C 1-6 alkyl; R 5 is independently hydrogen, C 1-6 alkyl, or —OR 6 , where R 6 is selected from the group consisting of hydrogen, C 1-6 alkyl, C 2-6 alkenyl,C 2-6 alkynyl, C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroarylC 1-6 alkyl; Y is C 1-6 alkylene, C 2-6 alkenylene, or C 2-6 alkylylene moiety; R 1 is C 1-6 alkyl, C 2-6 alkenyl, C 1-6 haloalkyl, C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroarylC 1-6 alkyl, wherein the alkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl are optionally substituted with one, two, three, or four groups that are each independently halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, —OR 7 , —SR 7 , —N(R 7 ) 2 , —C(O)R 7 , —C(O)OR 7 , —C(O)N(R 7 ) 2 , —S(O) 2 R 7 , —OC(O)R 7 , —OC(O)OR 7 , —OC(O)N(R 7 ) 2 , —N(R 7 )C(O)R 7 , —N(R 7 )C(O)OR 7 , or —N(R 7 )C(O)N(R 7 ) 2 , wherein each R 7 is independently hydrogen or C 1-6 alkyl; R 2 is hydrogen, halogen, C 1-6 alkyl, or —OR 8 , where R 8 is selected from the group consisting of hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroaryIC 1-6 alkyl, wherein the alkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl are optionally substituted with one, two, three, or four groups that are each independently halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, —OR 7 , —SR 7 , —N(R 7 ) 2 , —C(O)R 7 , —C(O)OR 7 , —C(O)N(R 7 ) 2 , —S(O) 2 R 7 , —OC(O)R 7 , —OC(O)OR 7 , —OC(O)N(R 7 ) 2 , —N(R 7 )C(O)R 7 , —N(R 7 )C(O)OR 7 , or —N(R 7 )C(O)N(R 7 ) 2 , wherein each R 7 is independently hydrogen or C 1-6 alkyl; or R 1 and R 2 together with the atoms to which they are attached form a C 3-12 cycloalkyl, heterocyclyl, aryl, or heteroaryl, each optionally substituted with one, two, three, or four groups that are each independently halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, —OR 7 , —SR 7 , —N(R 7 ) 2 , —C(O)R 7 , —C(O)OR 7 , —C(O)N(R 7 ) 2 , —S(O) 2 R 7 , —OC(O)R 7 , —OC(O)OR 7 , —OC(O)N(R 7 ) 2 , —N(R 7 )C(O)R 7 , —N(R 7 )C(O)OR 7 , or —N(R 7 )C(O)N(R 7 ) 2 ; and R 3 is hydrogen, C 1-6 alkyl, C 1-6 haloalkyl, —OR, —SR, or —NR 2 , and each R is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 1-6 haloalkyl, C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroarylC 1-6 alkyl, wherein the alkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl are optionally substituted with one, two, three, or four groups that are each independently halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, —OR 0 , —SR 0 , —N(R 0 ) 2 , —C(O)R 0 , —C(O)OR 0 , —C(O)N(R 0 ) 2 , —S(O) 2 R 0 , —OC(O)R 0 , —OC(O)OR 0 , —OC(O)N(R 0 ) 2 , —N(R 0 )C(O)R 0 , —N(R 0 )C(O)OR 0 , or —N(R 0 )C(O)N(R 0 ) 2 , wherein each R 0 is independently hydrogen or C 1-6 alkyl. 2 . A compound according to claim 1 , wherein A is optionally substituted phenyl having the formula: 3 . A compound according to claim 1 , wherein A is optionally substituted naphthyl having the formula: 4 . A compound according to any one of claims 1 - 3 , wherein X is —CH 2 —, —CHR 5 —, —NR 4 —, —O—, —S—, —SO—, —SO 2 —, —C(O)—, —C(NR 4 )—, or X is of formula wherein each n is independently 1, 2, or 3; each R 4 is independently hydrogen or C 1-6 alkyl; and R 5 is independently hydrogen, C 1-6 alkyl, or —OR 6 , where R 6 is selected from the group consisting of hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroarylC 1-6 alkyl. 5 . A compound according to claim 4 , wherein X is —CH 2 —, —CHR 5 —, —NR 4 —, —O—, —S—, —SO—, —SO 2 —, —C(O)—, —C(NR 4 )—, wherein each R 4 is independently hydrogen or C 1-6 alkyl; and R 5 is independently hydrogen, C 1-6 alkyl, or —OR 6 , where R 6 is selected from the group consisting of hydrogen, C 1-5 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroarylC 1-6 alkyl. 6 . A compound according to claim 4 , wherein X is —CH 2 — or —CHR 5 —, wherein R 5 is independently hydrogen, C 1-6 alkyl, or —OR 6 , where R 6 is selected from the group consisting of hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-12 cycloalkyl, heterocyclyl, aryl, arylC 1-6 alkyl, heteroaryl, or heteroarylC 1-6 alkyl. 7 . A compound according to claim 6 , wherein X is —CH 2 —. 8 . A compound according to claim 4 , wherein X is —NR 4 2 —, —O—, —S—, —SO—, —SO 2 —, —C(O)—, —C(NR 4 )—, wherein each R 4 is independently hydrogen or C 1-6 alkyl. 9 . A compound according to claim 8 , wherein X is —O—, —S—, —SO—, —SO 2 —, —C(O)—, or —C(NR 4 )—. 10 . A compound according to claim 8 , wherein X is —O—, —S—, —SO—, or —SO 2 —. 11 . A compound according to claim 8 , wherein X is —O—. 12 . A compound according to claim 8 , wherein X is —S—, —SO—, or —SO 2 —. 13 . A compound according to claim 8 , wherein X is —C(O)—. 14 . A compound according to claim 4 , wherein X is of formula and each n is independently 1 or 2. 15 . A compound according to claim 14 , wherein each n is independently 1. 16 . A compound according to any one of claims 1 - 3 wherein X is a bond. 17 . A compound according to any one of claims 1 - 3 , wherein X is a bond, —CH 2 —, —NH—, —S—, —SO 2 , —C(O)—, 18 . A compound according to any one of claims 1 - 3 , wherein X is —CH 2 —, —NH—, —S—, —SO 2 —, —C(O)—, 19 . A compound according to any one of claims 1 - 18 , wherein Y is C 1-6 alkylene or C 2-6 alkenylene. 20 . A compound according to claim 19 , wherein Y is C 1-4 alkylene or C 2-4 alkenylene. 21 . A compound according to claim 19 , wherein Y is C 1-4 alkylene. 22 . A compound according to claim 21 , wherein Y is methylene, ethylene, or propylene. 23 . A compound according to claim 22 , wherein Y is methylene or ethylene. 24 . A compound according to claim 19 , wherein
polycyclic · CPC title
Ethers · CPC title
with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains · CPC title
Esters of keto-carboxylic acids {or aldehydo-carboxylic acids} · CPC title
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.